{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:45:47Z","timestamp":1790520347578,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81073119"],"award-info":[{"award-number":["81073119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81611130078"],"award-info":[{"award-number":["81611130078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.molimm.2017.04.016","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T12:00:53Z","timestamp":1494590453000},"page":"188-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["TLR4 supports the expansion of FasL + CD5 + CD1d hi regulatory B cells, which decreases in contact hypersensitivity"],"prefix":"10.1016","volume":"87","author":[{"given":"Keng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2017.04.016_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/intimm\/dxv027","article-title":"Signals controlling the development and activity of regulatory B-lineage cells","volume":"27","author":"Baba","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cei.12745","article-title":"Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis","volume":"184","author":"Bashi","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0015","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice","volume":"182","author":"Blair","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/eji.201040992","article-title":"Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells","volume":"41","author":"Bodhankar","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1189\/jlb.0904536","article-title":"B lymphocytes mediate Fas-dependent cytotoxicity in MRL\/lpr mice","volume":"78","author":"Bonardelle","year":"2005","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molimm.2016.01.012","article-title":"The effect of Toll-like receptor 4 on beta2-glycoprotein I-induced B cell activation in mouse model","volume":"71","author":"Cheng","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0035","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.molimm.2017.04.016_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10875-016-0263-8","article-title":"New insights into IL-10 dependent and IL-10 independent mechanisms of regulatory B cell immune suppression","volume":"36","author":"Floudas","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0050","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.4049\/jimmunol.179.11.7225","article-title":"Intravenous transfusion of BCR-activated B cells protects NOD mice from Type 1 diabetes in an IL-10-dependent manner","volume":"179","author":"Hussain","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.04.016_bib0060","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jaci.2013.01.044","article-title":"B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells","volume":"131","author":"Jin","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.molimm.2017.04.016_bib0065","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molimm.2017.04.016_bib0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2017.04.016_bib0075","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.04.016_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2119\/molmed.2011.00333","article-title":"Multiple mechanisms of immune suppression by B lymphocytes","volume":"18","author":"Klinker","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.molimm.2017.04.016_bib0085","doi-asserted-by":"crossref","first-page":"e70131","DOI":"10.1371\/journal.pone.0070131","article-title":"Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10","volume":"8","author":"Klinker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2017.04.016_bib0090","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","volume":"180","author":"Lampropoulou","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.0105-2896.2009.00855.x","article-title":"Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity","volume":"233","author":"Lampropoulou","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2017.04.016_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-005-0355-6","article-title":"TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production","volume":"25","author":"Lenert","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejcb.2010.10.006","article-title":"Insights into the molecular regulation of FasL (CD178) biology","volume":"90","author":"Lettau","year":"2011","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0110","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1182\/blood-2012-05-432575","article-title":"Defective regulatory B-cell compartment in patients with immune thrombocytopenia","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.04.016_bib0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/08916934.2012.665528","article-title":"B cells as effectors and regulators of sex-biased arthritis","volume":"45","author":"Luckey","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2017.04.016_bib0120","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.70.2.812-819.2002","article-title":"Fas ligand-expressing B-1a lymphocytes mediate CD4+-T-cell apoptosis during schistosomal infection: induction by Interleukin 4 (IL-4) and IL-10","volume":"70","author":"Lundy","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2017.04.016_bib0125","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar2795","article-title":"Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis","volume":"11","author":"Lundy","year":"2009","journal-title":"Arthritis Res. Therapy"},{"key":"10.1016\/j.molimm.2017.04.016_bib0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4939-1161-5_7","article-title":"Characterization and activity of Fas ligand producing CD5(+) B cells","volume":"1190","author":"Lundy","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00011-009-0014-x","article-title":"Killer B lymphocytes: the evidence and the potential","volume":"58","author":"Lundy","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.molimm.2017.04.016_bib0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/dxv046","article-title":"Regulatory B10 cell development and function","volume":"27","author":"Lykken","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0145","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.178.6.3447","article-title":"B Cell regulation of CD4 + CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis","volume":"178","author":"Mann","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0150","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","article-title":"Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis","volume":"185","author":"Matsushita","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0155","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaci.2015.12.1319","article-title":"A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation","volume":"138","author":"Matsushita","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4939-1161-5_14","article-title":"Regulatory B cells in mouse models of systemic lupus erythematosus (SLE)","volume":"1190","author":"Matsushita","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","article-title":"The \u2018short\u2019 history of regulatory B cells","volume":"29","author":"Mauri","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2007.11.027","article-title":"B cell autonomous TLR signaling and autoimmunity","volume":"7","author":"Meyer-Bahlburg","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.molimm.2017.04.016_bib0175","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.TP.0000129799.96439.6F","article-title":"The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen","volume":"78","author":"Minagawa","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.molimm.2017.04.016_bib0180","doi-asserted-by":"crossref","first-page":"E2199","DOI":"10.1073\/pnas.1222446110","article-title":"Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells","volume":"110","author":"Montandon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2017.04.016_bib0185","doi-asserted-by":"crossref","first-page":"e22464","DOI":"10.1371\/journal.pone.0022464","article-title":"Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice","volume":"6","author":"Poe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2017.04.016_bib0190","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1172\/JCI118274","article-title":"Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis","volume":"96","author":"Racke","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2017.04.016_bib0195","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0200","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.4049\/jimmunol.1303397","article-title":"CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis","volume":"193","author":"Sheng","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0205","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/rheumatology\/kel095","article-title":"A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis","volume":"45","author":"Szodoray","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.molimm.2017.04.016_bib0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2015.10.017","article-title":"BIP induces mice CD19(hi) regulatory B cells producing IL-10 and highly expressing PD-L1, FasL","volume":"69","author":"Tang","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0215","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0220","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4049\/jimmunol.167.2.1081","article-title":"Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice","volume":"167","author":"Tian","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0225","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0230","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2017.04.016_bib0235","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","volume":"182","author":"Yanaba","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0240","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ajpath.2010.10.022","article-title":"IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model","volume":"178","author":"Yanaba","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0245","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1189\/jlb.1112562","article-title":"Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation","volume":"94","author":"Yanaba","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0250","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.4049\/jimmunol.0902551","article-title":"Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells","volume":"184","author":"Yang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cmi.2012.60","article-title":"Regulatory B cells in autoimmune diseases","volume":"10","author":"Yang","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0260","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-3083.2012.02752.x","article-title":"B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells","volume":"76","author":"Yehudai","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.02.003","article-title":"New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids","volume":"270","author":"de Andres","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2017.04.016_bib0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4939-1161-5_10","article-title":"Toll-like receptor ligation for the induction of regulatory B cells","volume":"1190","author":"van der Vlugt","year":"2014","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017301153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017301153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T23:01:06Z","timestamp":1535842866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589017301153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":54,"alternative-id":["S0161589017301153"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.04.016","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4 supports the expansion of FasL+CD5+CD1dhi regulatory B cells, which decreases in contact hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}